Diffusion Imaging for Therapy Response Assessment of Brain Tumor

Neuroimaging Clinics of North America

Volumn 19, Issue 4, 2009, Pages 559-571

  Chenevert, Thomas L ^a   Ross, Brian D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apparent diffusion coefficient; Brain tumor; Diffusion anisotropy; Diffusion weighted MRI; Parametric response map; Treatment response

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE;

ANISOTROPY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INFILTRATION; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DOSE RESPONSE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; NEUROIMAGING; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CLASSIFICATION;

BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; TREATMENT OUTCOME;

EID: 70549113766     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2009.08.009     Document Type: Review

References (85)

1. Horner M.J., Ries L.A.G., Krapcho M., et al. SEER cancer statistics review, 1975-2006 (2009), National Cancer Institute, Bethesda (MD)
2. Hegi M.E., Diserens A.C., Gorlia T., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 10 (2005) 997-1003
3. Keles G.E., Chang E.F., Lamborn K.R., et al. Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg 105 1 (2006) 34-40
4. Sanai N., and Berger M.S. Glioma extent of resection and its impact on patient outcome. Neurosurgery 62 4 (2008) 753-764 [discussion: 264-6]
5. Gaspar L.E., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 4 (2000) 1001-1006
6. Scott C.B., Scarantino C., Urtasun R., et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40 1 (1998) 51-55
7. Brandes A.A., Franceschi E., Tosoni A., et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26 13 (2008) 2192-2197
8. Brandsma D., Stalpers L., Taal W., et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9 5 (2008) 453-461
9. Taal W., Brandsma D., de Bruin H.G., et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 113 2 (2008) 405-410
10. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 3 (2000) 205-216
11. Kauppinen R.A. Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed 15 1 (2002) 6-17
12. Norris D.G. The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed 14 2 (2001) 77-93
13. Szafer A., Zhong J., and Gore J.C. Theoretical model for water diffusion in tissues. Magn Reson Med 33 5 (1995) 697-712
14. Haacke E.M., Brown R.W., Thompson M.R., et al. Magnetic resonance imaging: physical principles and sequence design (1999), John Wiley & Sons, Inc, New York
15. Hagmann P., Jonasson L., Maeder P., et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 26 Suppl 1 (2006) S205-S223
16. Le Bihan D., Mangin J.F., Poupon C., et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13 4 (2001) 534-546
17. Basser P.J., and Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis. A technical review. NMR Biomed 15 7-8 (2002) 456-467
18. Sorensen A.G., Buonanno F.S., Gonzalez R.G., et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 199 2 (1996) 391-401
19. Warach S., Gaa J., Siewert B., et al. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 37 2 (1995) 231-241
20. Clark C.A., and Le Bihan D. Water diffusion compartmentation and anisotropy at high b values in the human brain. Magn Reson Med 44 6 (2000) 852-859
21. Le Bihan D. The wet mind: water and functional neuroimaging. Phys Med Biol 52 7 (2007) R57-R90
22. Mulkern R.V., Gudbjartsson H., Westin C.F., et al. Multi-component apparent diffusion coefficients in human brain. NMR Biomed 12 1 (1999) 51-62
23. Mulkern R.V., Haker S.J., and Maier S.E. On high b diffusion imaging in the human brain: ruminations and experimental insights. Magn Reson Imaging 27 8 (2009) 1151-1162
24. Bennett K.M., Schmainda K.M., Bennett R.T., et al. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn Reson Med 50 4 (2003) 727-734
25. Lee J.H., and Springer Jr. C.S. Effects of equilibrium exchange on diffusion-weighted NMR signals: the diffusigraphic shutter-speed. Magn Reson Med 49 3 (2003) 450-458
26. Kwee T.C., Galba'n C.J., Tsien C., et al. Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas. NMR Biomed (2009) in press
27. Beaulieu C. The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 15 7-8 (2002) 435-455
28. Chenevert T.L., Brunberg J.A., and Pipe J.G. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 177 2 (1990) 401-405
29. Mori S., Frederiksen K., van Zijl P.C., et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 51 3 (2002) 377-380
30. Mori S., and van Zijl P.C. Fiber tracking: principles and strategies: a technical review. NMR Biomed 15 7-8 (2002) 468-480
31. Moseley M. Diffusion tensor imaging and aging: a review. NMR Biomed 15 7-8 (2002) 553-560
32. Moseley M.E., Kucharczyk J., Asgari H.S., et al. Anisotropy in diffusion-weighted MRI. Magn Reson Med 19 2 (1991) 321-326
33. Alexander A.L., Hasan K., Kindlmann G., et al. A geometric analysis of diffusion tensor measurements of the human brain. Magn Reson Med 44 2 (2000) 283-291
34. Papadakis N.G., Xing D., Houston G.C., et al. A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Imaging 17 6 (1999) 881-892
35. Westin C.F., Maier S.E., Mamata H., et al. Processing and visualization for diffusion tensor MRI. Med Image Anal 6 2 (2002) 93-108
36. Chenevert T.L., McKeever P.E., and Ross B.D. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3 9 (1997) 1457-1466
37. Lope-Piedrafita S., Garcia-Martin M.L., Galons J.P., et al. Longitudinal diffusion tensor imaging in a rat brain glioma model. NMR Biomed 21 8 (2008) 799-808
38. Melhem E.R., Mori S., Mukundan G., et al. Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol 178 1 (2002) 3-16
39. Gauvain K.M., McKinstry R.C., Mukherjee P., et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 177 2 (2001) 449-454
40. Guo A.C., Cummings T.J., Dash R.C., et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224 1 (2002) 177-183
41. Kono K., Inoue Y., Nakayama K., et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22 6 (2001) 1081-1088
42. Sugahara T., Karogi Y., Kochi M., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9 1 (1999) 53-60
43. Castillo M., Smith J.K., Kwock L., et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 22 1 (2001) 60-64
44. Gupta R.K., Sinha U., Cloughesy T.F., et al. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 41 1 (1999) 2-7
45. Bastin M.E., Sinha S., Whittle I.R., et al. Measurements of water diffusion and T1 values in peritumoural oedematous brain. Neuroreport 13 10 (2002) 1335-1340
46. Sinha S., Bastin M.E., Whittle I.R., et al. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 23 4 (2002) 520-527
47. Provenzale J.M., McGraw P., Mhatre P., et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232 2 (2004) 451-460
48. Stadnik T.W., Chaskis C., Michotte A., et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 22 5 (2001) 969-976
49. Field A.S., and Alexander A.L. Diffusion tensor imaging in cerebral tumor diagnosis and therapy. Top Magn Reson Imaging 15 5 (2004) 315-324
50. Brunberg J.A., Chenevert T.L., McKeever P.E., et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 16 2 (1995) 361-371
51. Krabbe K., Gideon P., Wagn P., et al. MR diffusion imaging of human intracranial tumours. Neuroradiology 39 7 (1997) 483-489
52. Lu S., Ahn D., Johnson G., et al. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 24 5 (2003) 937-941
53. Lu S., Ahn D., Johnson G., et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 232 1 (2004) 221-228
54. Inoue T., Ogasawara K., Beppu T., et al. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg 107 3 (2005) 174-180
55. Wieshmann U.C., Symms M.R., Parker G.J., et al. Diffusion tensor imaging demonstrates deviation of fibres in normal appearing white matter adjacent to a brain tumour. J Neurol Neurosurg Psychiatr 68 4 (2000) 501-503
56. Pierpaoli C., Jezzard P., Basser P.J., et al. Diffusion tensor MR imaging of the human brain. Radiology 201 3 (1996) 637-648
57. Shimony J.S., McKinstry R.C., Akbudak E., et al. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology 212 3 (1999) 770-784
58. Field A.S., Alexander A.L., Wu Y.C., et al. Diffusion tensor eigenvector directional color imaging patterns in the evaluation of cerebral white matter tracts altered by tumor. J Magn Reson Imaging 20 4 (2004) 555-562
59. Mardor Y., Roth Y., Ochershvilli A., et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6 2 (2004) 136-142
60. Chenevert T.L., Stegman L.D., Taylor J.M., et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92 24 (2000) 2029-2036
61. Hall D.E., Moffat B.A., Stojanovska J., et al. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res 10 23 (2004) 7852-7859
62. Henning E.C., Azuma C., Sotak C.H., et al. Multispectral tissue characterization in a RIF-1 tumor model: monitoring the ADC and T2 responses to single-dose radiotherapy (part II). Magn Reson Med 57 3 (2007) 513-519
63. Kim H., Morgan D.E., Buchsbaum D.J., et al. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res 68 20 (2008) 8369-8376
64. McConville P., Hambardzumyan D., Moody J.B., et al. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. Clin Cancer Res 13 10 (2007) 2897-2904
65. Stegman L.D., Rehemtulla A., Hamstra D.A., et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 7 12 (2000) 1005-1010
66. Galons J.P., Altbach M.I., Paine-Murrieta G.D., et al. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1 2 (1999) 113-117
67. Jennings D., Hatton B.N., Guo J., et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 4 3 (2002) 255-262
68. Kim S., Loevner L., Quon H., et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15 3 (2009) 986-994
69. Lee K.C., Bradley D.A., Hussain M., et al. A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9 12 (2007) 1003-1011
70. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 7 (2006) 843-847
71. Yankeelov T.E., Lepage M., Chakravarthy A., et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25 1 (2007) 1-13
72. Kamel I.R., Liapi E., Reyes D.K., et al. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 250 2 (2009) 466-473
73. Dudeck O., Zeile M., Pink D., et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 27 5 (2008) 1109-1113
74. Harry V.N., Semple S.I., Gilbert F.J., et al. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111 2 (2008) 213-220
75. Schubert M.I., Wilke M., Muller-Weihrich S., et al. Diffusion-weighted magnetic resonance imaging of treatment-associated changes in recurrent and residual medulloblastoma: preliminary observations in three children. Acta Radiol 47 10 (2006) 1100-1104
76. Mardor Y., Pfeffer R., Spiegelmann R., et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21 6 (2003) 1094-1100
77. Tomura N., Narita K., Izumi J., et al. Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30 3 (2006) 496-500
78. Huang C.F., Chou H.H., Tu H.T., et al. Diffusion magnetic resonance imaging as an evaluation of the response of brain metastases treated by stereotactic radiosurgery. Surg Neurol 69 1 (2008) 62-68 [discussion: 68]
79. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102 15 (2005) 5524-5529
80. Meyer C.R., Boes J.L., Kim B., et al. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1 3 (1997) 195-206
81. Meyer C., Chenevert T., Galban C., et al. Parametric response mapping: a voxel-based analysis of quantitative diffusion MRI changes for individualized assessment of primary breast cancer response to therapy. Proceedings 17th Scientific Meeting, International Society for Magnetic Resonance in Medicine (April 18-24, 2009) 2223
82. Galbán C.J., Chenevert T.L., Meyer C.R., et al. The parametric response map: an imaging biomarker for early cancer treatment outcome. Nature Medicine 15 5 (2009) 572-576
83. Wai Y., Chu J., Wang C., et al. An integrated diffusion map for the analysis of diffusion properties: a feasibility study in patients with acoustic neuroma. Acad Radiol 16 4 (2009) 428-434
84. Ellingson B., Malkin M., Rand S., et al. Functional diffusion maps applied to FLAIR abnormal areas are valuable for the clinical monitoring of recurrent brain tumors. Proceedings 17th Scientific Meeting, International Society for Magnetic Resonance in Medicine (April 18-24, 2009) 285
85. Hamstra D.A., Galban C.J., Meyer C.R., et al. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 26 20 (2008) 3387-3394